AfricaRegulatory

African Pharmaceutical Regulatory Intelligence

ETHIONAMIDE

10 registrations across 3 African markets— 6 active

Markets with ETHIONAMIDE

Recent registrations

Brand / ProductMarketHolderStatusExpires
FAMS ETHIONAMIDE 250 mg🇿🇦South AfricaAdcock Ingram LimitedsuspendedDec 2024
DYNA ETHIONAMIDE 250 mg🇿🇦South AfricaPharma Dynamics (Pty) LtdsuspendedAug 2023
ETHIONAMIDE 250MG TABLET
TABLET
🇲🇼MalawiexpiredJun 2012
ETHIONAMIDE 250MG TABLET
TABLET
🇲🇼MalawiexpiredJun 2012
ETHIONAMIDE🇿🇦South AfricaPharmacare Limited û WoodmeadactiveJan 1900
Ethionamide🌍WWMicro Labs Limitedactive
Ethionamide Tablet, Film-coated 250mg
Tablet, Film-coated
🌍WWMacleods Pharmaceuticals Ltdactive
Ethionamide🌍WWPen Tsao Chemical Industry Ltdactive
Ethionamide Tablet, Dispersible 125mg
Tablet, Dispersible
🌍WWMacleods Pharmaceuticals Ltdactive
Ethionamide Tablet, Film-coated 250mg
Tablet, Film-coated
🌍WWMicro Labs Limitedactive

ETHIONAMIDE in Africa — Regulatory Overview

ETHIONAMIDE is registered across 3 African markets with 10 total product registrations on file. Data is sourced directly from official national drug regulatory authorities including WW, South Africa, Malawi. AfricaRegulatory refreshes this data daily from official government sources.

Of the 10 registrations, 6 (60%) are currently active. Regulatory affairs teams use AfricaRegulatory to track registration expiry dates, identify market incumbents, and monitor approval status across African markets without manual monitoring of each national regulator.